Trial Profile
A Prospective Randomized Comparative Study of Efficacy and Safety of Combined Deferiprone (DFP) and Deferasirox Versus DFP and Desferrioxamine (DFO) Therapy in Diseases With Severe Iron Overload
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Deferasirox (Primary) ; Deferiprone (Primary) ; Deferoxamine (Primary)
- Indications Beta-thalassaemia; Iron overload
- Focus Therapeutic Use
- 17 Jun 2021 Results (n=24) assessing immune profile of pediatric multi-transfused patients with beta thalassemia presented at the 26th Congress of the European Haematology Association
- 28 Apr 2014 New trial record